Clinical Trials Directory

Trials / Completed

CompletedNCT02439580

Effect of Annona Muricata Leaves on Colorectal Cancer Patients and Colorectal Cancer Cells

Effect of Annona Muricata Leaves on Nutritional Status, Quality of Life, Fecal Butyrate, Inflammation, and Colorectal Cancer Cells

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Annona muricata L., include the leaves, is found to contain biologically active Annonaceous acetogenins and plant polyphenols that are important components of human diet and a number of them are considered to have chemopreventive and therapeutic properties against cancer. To confirm previous findings in in vitro, animal study and traditionally use, a human, ex vivo and in vitro studies were conducted to evaluate the effects of consecutive ingestion of A. muricata leaves extract for eight weeks.

Detailed description

Colorectal cancer patients were randomly assigned to receive either A. muricata leaves extract or placebo. Dietary intakes and anthropometry were assessed with food record every two weeks. Blood parameters, nutritional status, quality of life, fecal butyrate level, and systemic inflammation of patient were assessed at the beginning and the end of study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAnnona muricata extractethanol-soluble fraction of water extract
DIETARY_SUPPLEMENTPlacebomaltose

Timeline

Start date
2013-10-01
Primary completion
2014-06-01
Completion
2014-10-01
First posted
2015-05-12
Last updated
2015-05-14

Source: ClinicalTrials.gov record NCT02439580. Inclusion in this directory is not an endorsement.